SPX3,778.86-6.52 -0.17%
DIA306.99-0.83 -0.27%
IXIC10,998.24-30.50 -0.28%

BRIEF-U.S. FDA Decision On Novavax’s Covid Shots Could Be Delayed To Review Changes In Manufacturing - CNBC

reuters.com · 06/09/2022 07:03
BRIEF-U.S. FDA Decision On Novavax’s Covid Shots Could Be Delayed To Review Changes In Manufacturing - CNBC

-

  • U.S. FDA DECISION ON NOVAVAX’S COVID SHOTS COULD BE DELAYED TO REVIEW CHANGES IN MANUFACTURING - CNBC

Source text: [https://cnb.cx/3H9J4Ba]

Further company coverage: NVAX


((reuters.briefs@thomsonreuters.com;))